Chief Executive Officer
Lineage Cell Therapeutics, Inc.
Carlsbad, California, United States
Mr. Culley is an experienced public biopharmaceutical company executive, and has served as Lineage's Chief Executive Officer since September 2018. Mr. Culley has more than 25 years of business and scientific experience in the life sciences industry and his broad experience includes the clinical development of pharmaceutical products from research through Phase 3, corporate partnering, institutional capital raising, and numerous other activities. Mr. Culley previously served as Chief Executive Officer of Mast Therapeutics, Inc. (MSTX), from 2010, and was also a member of its board of directors from 2011, until Mast’s merger with Savara, Inc. (SVRA) in April 2017. Mr. Culley’s earlier positions included leadership roles in business development and technology transfer and as an early discovery researcher for Neurocrine Biosciences (NASDAQ: NBIX). Mr. Culley received a B.S. in biology from Boston College, a Masters in biochemistry and molecular biology from the University of California Santa Barbara, and an M.B.A. from The Johnson School at Cornell University.
Disclosure information not submitted.
Tuesday, April 25, 2023
10:00 AM – 10:30 AM ET